Harvard Bioscience outlines Q2 revenue target of $18M-$20M amid product launches and cost actions

Stock Information for Harvard Bioscience Inc.

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Harvard Bioscience Inc.

Harvard Bioscience Appoints John Duke to Board of Directors
Harvard Bioscience Announces First Quarter 2025 Financial Results
Harvard Bioscience Schedules First Quarter 2025 Earnings Conference Call for May 12, 2025 at 8:00 AM ET
Harvard Bioscience Announces CFO Transition
Harvard Bioscience, Inc. to Participate in Two Investor Conferences in March 2025
Harvard Bioscience Announces Fourth Quarter and Full-Year 2024 Financial Results
Harvard Bioscience to Showcase Latest Solutions for Preclinical and Organoid Applications at Society of Toxicology Meeting
Harvard Bioscience Schedules Fourth Quarter 2024 Earnings Conference Call for March 12, 2025 at 8:00 AM ET

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.